Skip to main content

Table 2 Antifungal susceptibility of Candida bloodstream isolates in patients during the study period

From: Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China

  Fluconazole Itraconazole Ketoconazole Voriconazole
Species No. of isolates tested %S# No. of isolates tested %S No. of isolates tested %S No. of isolates tested %S
C. albicans 31 23 (74.2) 31 29 (93.6) 6 3 (50.0) 22 22 (100.0)
C. parapsilosis 26 15 (57.7) 26 25 (96.2) 2 1 (50.0) 22 22 (100.0)
C. glabrata 11 1 (9.1) 11 1 (9.1) 1 0 (0) 5 5 (100.0)
C. tropicalis 38 12 (31.6) 38 25 (65.8) 5 0 (0) 23 21 (91.3)
C. krusei 3 0 (0) 3 1 (33.3) 1 0 (0) 3 3 (100.0)
C. guilliermondii 6 4 (66.7) 6 5 (83.3) 0 0 (0) 5 5 (100.0)
Other* 16 4 (25.0) 16 5 (31.3) 3 3 (100.0) 12 12 (100.0)
Total 128 59 (46.1) 131 91 (69.5)* 18 7 (38.9) 92 90 (97.8)
  1. *; Others include: C. pelliculosa, C. famata and C. haemuloni.
  2. #; Abbreviations: S susceptible.